Continuum Advisory’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.7M | Buy |
2,175
+248
| +13% | +$193K | 0.2% | 103 |
|
|
2025
Q1 | $1.59M | Buy |
1,927
+333
| +21% | +$275K | 0.2% | 107 |
|
|
2024
Q4 | $1.23M | Buy |
1,594
+93
| +6% | +$71.8K | 0.16% | 131 |
|
|
2024
Q3 | $1.18M | Buy |
1,501
+358
| +31% | +$281K | 0.15% | 145 |
|
|
2024
Q2 | $1.03M | Sell |
1,143
-3
| -0.3% | -$2.72K | 0.15% | 148 |
|
|
2024
Q1 | $884K | Sell |
1,146
-65
| -5% | -$50.2K | 0.13% | 165 |
|
|
2023
Q4 | $706K | Sell |
1,211
-45
| -4% | -$26.2K | 0.1% | 225 |
|
|
2023
Q3 | $674K | Sell |
1,256
-286
| -19% | -$154K | 0.11% | 225 |
|
|
2023
Q2 | $723K | Sell |
1,542
-22
| -1% | -$10.3K | 0.12% | 215 |
|
|
2023
Q1 | $537K | Buy |
1,564
+198
| +14% | +$68K | 0.09% | 254 |
|
|
2022
Q4 | $500K | Sell |
1,366
-485
| -26% | -$177K | 0.09% | 254 |
|
|
2022
Q3 | $598K | Buy |
1,851
+18
| +1% | +$5.82K | 0.11% | 205 |
|
|
2022
Q2 | $594K | Sell |
1,833
-33
| -2% | -$10.7K | 0.11% | 227 |
|
|
2022
Q1 | $545K | Buy |
1,866
+772
| +71% | +$225K | 0.1% | 231 |
|
|
2021
Q4 | $302K | Sell |
1,094
-6
| -0.5% | -$1.66K | 0.07% | 244 |
|
|
2021
Q3 | $254K | Buy |
1,100
+63
| +6% | +$14.5K | 0.07% | 249 |
|
|
2021
Q2 | $238K | Buy |
+1,037
| New | +$238K | 0.07% | 241 |
|